It seems like with each new Musk innovation, a new Twitter replacement appears in response. But Threads is backed by Meta and available in just a few clicks for an Instagram user. Could it be the one?Guest: Mike Isaac, technology reporter for the New York Times.If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Even if you like the convenience of your phone unlocking after it reads your face, there are reasons to be wary of the TSA bringing facial recognition technology to the airport. Guest: Geoffrey Fowler, technology columnist for the Washington Post.If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

A shortage of basic chemotherapy drugs to treat cancer is jeopardizing the care of hundreds of thousands of patients. The drugs aren’t expensive, or patented—so where are they? Guest: Ed Yong, science journalist at The Atlantic.Host: Lizzie O'LearyIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Semaglutide, better known by its brand name Ozempic, has been making headlines as a weight loss drug – despite only having FDA approval to treat diabetes. Now, some say it doesn’t just quell cravings for food – it helps quiet cravings for alcohol, drugs, and other compulsive behaviors. For years, researchers have been studying semaglutide's effectiveness as an addiction cure in animals. What have they found? And – does it actually work? Guest: Sarah Zhang covers health and medicine for The AtlanticIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

On Wednesday, the Federal Trade Commission sued Amazon, accusing the online giant of “tricking and trapping people into recurring subscriptions.” The complaint says Amazon “knowingly duped millions of consumers into unknowingly enrolling in Amazon Prime." With murmurs of a larger antitrust probe against Amazon just around the corner, how serious is this suit for the tech giant? Guest: Leah Nylen, antitrust reporter at BloombergIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

One son was preparing to take over George Soros’s multi-billion-dollar empire. Then, there was a falling out, and a new heir-apparent was chosen. Who is Alex Soros? And, as he takes over for one of the most influential figures in American politics, what can we expect from him? Guest: Gregory Zuckerman, special writer at the Wall Street JournalHost: Emily PeckIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Across Reddit, thousands of forums have gone “private” and effectively disappeared. Users are protesting the site’s plan to capitalize on its data, which has been enjoyed for free by people making third-party apps for Reddit, as well as some of the world’s biggest companies training their A.I.Guest: Sarah Needleman, reporter for the Wall Street Journal who writes about interactive entertainment and social mediaHost: Emily PeckIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

As “deep fakes” have demonstrated, it’s getting easier and easier to swap an actor for a digital likeness—something that contributed to the Screen Actors Guild voting to authorize joining the writers on strike. Guest: Heather Tal Murphy, Slate writer covering tech, business, and A.I.Host: Lizzie O'LearyIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.Check out AWS Insiders here: https://link.chtbl.com/awsinsiders?sid=podcast.whatnexttbd Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, the SEC sued Binance, the largest crypto exchange in the world, and Coinbase, the largest crypto exchange in the US. Is it a sign that the glory days of crypto are gone?Guest: Stacy-Marie Ishmael, managing editor for crypto at Bloomberg NewsHost: Lizzie O'LearyIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Until recently, Nvidia was a company known for graphics cards—a brand name among gamers but not necessarily the general public. But as part of the A.I. boom, Nvidia’s stock has skyrocketed, putting the company in Silicon Valley’s trillion-dollar valuation class with Apple, Meta, and Alphabet—briefly, at least.Guest: Don Clark, freelance reporter specializing in chips and enterprise tech.Host: Emily PeckIf you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices